12 recruiting, 11 completed, 11 unknown, 6 active not recruiting. 19 Not applicable, 15 Phase 2, 7 Phase 3, 5 Phase 1, 1 Phase 4.
Follow Stereotactic Ablative Radiotherapy: new trials by email Literature Review of Stereotactic Ablative Radiotherapy trials Research Report on Stereotactic Ablative Radiotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II Stereotactic Ablative Radiotherapy, Physician's choice of systemic treatment - Breast Cancer, Metastatic, Metastatic Breast Cancer | Not applicable | Not yet recruiting | Peter MacCallum Cancer Centre, Australia | 74 | 2026-11-01 | 2026-09-18 |
| SBRT Plus QL1706 as Second-Line Therapy for Hepatocellular Carcinoma Stereotactic Body Radiation Therapy (SBRT), QL1706 - HCC - Hepatocellular Carcinoma | Phase 4 | Not yet recruiting | Hebei Medical University Fourth Hospital | 36 | 2026-07-01 | 2026-06-25 |
| Total RadIoTherapy of Oligometastatic caNcerS stereotactic ablative radiotherapy - Oligometastatic Malignant Solid Neoplasm | Phase 3 | Recruiting | University of California, San Diego | 300 | 2024-11-12 | 2026-10-16 |
| Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study) Stereotactic body radiotherapy (SBRT), axitinib ± immune checkpoint inhibitors (ICIs), lenvatinib ± ICIs, cabozantinib ± ICIs, sunitinib and pazopanib - Renal Cell Carcinoma (Kidney Cancer), Kidney Cancer Metastatic | Phase 3 | Recruiting | Sun Yat-sen University | 252 | 2024-09-18 | 2026-01-15 |
| Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial Stereotactic Ablative Radiotherapy, Best Practice - Oligometastasis, Lung Cancer | Phase 3 | Recruiting | Roswell Park Cancer Institute | 800 | 2024-09-18 | 2026-02-04 |
| Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer Computed Tomography, Cone-Beam Computed Tomography, Image-Guided Adaptive Radiation Therapy - Localized Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 | Not applicable | Recruiting | Mayo Clinic | 164 | 2024-08-15 | 2026-10-14 |
| Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors Tislelizumab, Low Dose Radiotherapy, Stereotactic Ablative Radiotherapy - Solid Tumor | Phase 1 | Recruiting | Sichuan University | 24 | 2024-04-18 | 2026-05-01 |
| Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative Radiotherapy Minimally invasive pulmonary metastasectomy, Stereotactic ablative radiotherapy - Lung Metastases, Colorectal Cancer Metastatic | Not applicable | Not yet recruiting | Amsterdam UMC, location VUmc | 394 | 2024-01-01 | 2023-04-11 |
| Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study Computed Tomography, Magnetic Resonance Imaging, Questionnaire Administration - Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 | Phase 3 | Active not recruiting | ECOG-ACRIN Cancer Research Group | 472 | 2023-12-27 | 2026-09-15 |
| Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc stereotactic ablative radiotherapy, Pluvicto, topical testosterone - Prostate Cancer | Phase 2 | Recruiting | VA Office of Research and Development | 60 | 2023-12-14 | 2025-12-31 |
| Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial Stereotactic Ablative Radiotherapy, Resection, Microwave Ablation - Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 | Phase 2 | Recruiting | Alliance for Clinical Trials in Oncology | 146 | 2023-10-09 | 2026-10-02 |
| A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor. Palliative Radiotherapy, Chemotherapy, Hormone therapy - Metastatic Tumor | Phase 3 | Recruiting | David Palma | 180 | 2023-10-06 | 2025-12-31 |
| Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial Avelumab, Axitinib, Biospecimen Collection - Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 | Phase 2 | Recruiting | NRG Oncology | 240 | 2023-02-01 | 2026-09-18 |
| Stereotactic Ablative Radiotherapy (SAbR) for Treatment of Ventricular Tachycardia (VT) Refractory Standard Invasive Ablation Techniques Stereotactic ablative radiotherapy - Tachycardia, Ventricular | Not applicable | Withdrawn | University of Texas Southwestern Medical Center | 2023-02-01 | 2022-08-17 | |
| Stereotactic Ablative Radiotherapy for the Treatment of Refractory Ventricular Tachycardia Stereotactic ablative radiotherapy - Radiotherapy; Complications, Ventricular Tachycardia | Not applicable | Completed | Barts & The London NHS Trust | 4 | 2023-01-12 | 2026-09-22 |
| NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma Pembrolizumab, Stereotactic Ablative Radiotherapy, Nephrectomy - Renal Cell Carcinoma, Clear Cell, Somatic | Phase 2 | Unknown | Peter MacCallum Cancer Centre, Australia | 20 | 2022-02-08 | 2024-05-16 |
| Targeted Radiotherapy for Recurrent Prostate Cancer Stereotactic ablative radiotherapy, Current standard template-based salvage therapy - Prostate Cancer Recurrence After Radical Prostatectomy | Not applicable | Unknown | Tampere University Hospital | 40 | 2022-01-01 | 2021-10-05 |
| StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias Stereotactic Ablative Radiotherapy - Cardiac Arrhythmia | Not applicable | Recruiting | University Health Network, Toronto | 60 | 2021-12-14 | 2026-03-05 |
| Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer stereotactic body radiotherapy, androgen deprivation therapy, Radiotherapy - Prostate Cancer Metastatic, Radiation Therapy | Not applicable | Recruiting | Karin Soderkvist | 118 | 2021-10-27 | 2026-02-17 |
| SterEotactic AbLative Radiotherapy in PatiEnts With HypertrophiC ObstrucTive Cardiomyopathy stereotactic ablative radiotherapy - Hypertrophic Obstructive Cardiomyopathy | Not applicable | Completed | Second Xiangya Hospital of Central South University | 5 | 2021-01-12 | 2022-11-30 |
Showing 20 of 46. Sign in to see all of them.
Prostatic Neoplasms (9) · Carcinoma, Hepatocellular (6) · Carcinoma, Renal Cell (6) · Carcinoma, Non-Small-Cell Lung (5) · Neoplasm Metastasis (5) · Colorectal Neoplasms (2) · Lung Neoplasms (2) · Tachycardia, Ventricular (2) · Adenocarcinoma of Lung (1) · Arrhythmias, Cardiac (1) · Breast Neoplasms (1) · Carcinoma, Squamous Cell (1) · Cardiomyopathy, Hypertrophic (1) · Colonic Neoplasms (1) · Erectile Dysfunction (1)
Korea Cancer Center Hospital (3) · University Health Network, Toronto (3) · Amsterdam UMC, location VUmc (2) · British Columbia Cancer Agency (2) · David Palma (2) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2) · Peter MacCallum Cancer Centre, Australia (2) · Radiation Therapy Oncology Group (2) · University of Texas Southwestern Medical Center (2) · Alliance for Clinical Trials in Oncology (1) · Barts & The London NHS Trust (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · ECOG-ACRIN Cancer Research Group (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · H. Lee Moffitt Cancer Center and Research Institute (1)
United States (15) · Canada (14) · Australia (6) · United Kingdom (5) · Netherlands (4) · South Korea (4) · China (3) · Ireland (2) · Switzerland (2) · Belgium (1) · Brazil (1) · Finland (1) · France (1) · Hong Kong (1) · Italy (1)
Mi-Sook Kim, MD, PhD (3) · David Palma, MD (2) · Abraham Alexander, MD (1) · Alejandro Berlin, MD (1) · Alexander Louie, MD (1) · Andrew Loblaw, MD (1) · Anna ME Bruynzeel, MD PhD (1) · Anurag Singh, MD (1) · Chris Ryerson, MD (1) · David Palma, MD, PhD (1) · Elizabeth M. Gore, MD (1) · Fabio Arcidiacono, MD (1) · Fabio Trippa, MD (1) · Feng-Ming Hsu, MD (1)
PMID 30982687, PMID 32484754, PMID 19403881, PMID 22823994, PMID 27441744, PMID 28973074, PMID 29852037, PMID 31067138, PMID 31426760, PMID 31829203, PMID 31908301, PMID 32327479, PMID 32370765, PMID 32388150, PMID 32822540, PMID 33608212, PMID 34430382, PMID 35094066, PMID 35243022, PMID 36001857, PMID 36288758, PMID 36358757, PMID 36581914, PMID 36652155, PMID 37105304, PMID 37435562, PMID 37451182, PMID 37503357, PMID 38042451, PMID 38350888, PMID 38451491, PMID 38519913, PMID 39244532, PMID 39699905, PMID 40049196, PMID 40097400, PMID 41290048, PMID 41882599, PMID 42692526
2015 (1), I01CX002775 (1), P30CA072720 (1), R01EB027898 (1), U10CA021661 (1), U10CA180820 (1), U10CA180868 (1)